177 related articles for article (PubMed ID: 10464846)
1. A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group.
Wallaert B; Brun P; Ostinelli J; Murciano D; Champel F; Blaive B; Montané F; Godard P
Respir Med; 1999 Jan; 93(1):33-8. PubMed ID: 10464846
[TBL] [Abstract][Full Text] [Related]
2. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group.
Gunn SD; Ayres JG; McConchie SM
Eur J Clin Pharmacol; 1995; 48(1):23-8. PubMed ID: 7621843
[TBL] [Abstract][Full Text] [Related]
5. Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.
Brambilla C; Chastang C; Georges D; Bertin L
Allergy; 1994 Jul; 49(6):421-6. PubMed ID: 7915501
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
Boyd G
Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist.
Fitzpatrick MF; Mackay T; Driver H; Douglas NJ
BMJ; 1990 Dec; 301(6765):1365-8. PubMed ID: 1980220
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
9. Salmeterol xinafoate in children on high dose inhaled steroids.
Russell G; Williams DA; Weller P; Price JF
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
[TBL] [Abstract][Full Text] [Related]
10. Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Cazzola M; Calderaro F; Califano C; Di Pema F; Vinciguerra A; Donner CF; Matera MG
Eur J Clin Pharmacol; 1999 Jan; 54(11):829-33. PubMed ID: 10027655
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
[TBL] [Abstract][Full Text] [Related]
12. Comparative study using oral solutions of bambuterol once daily or terbutaline three times daily in 2-5-year-old children with asthma. Bambuterol Multicentre Study Group.
Kuusela AL; Marenk M; Sandahl G; Sanderud J; Nikolajev K; Persson B
Pediatr Pulmonol; 2000 Mar; 29(3):194-201. PubMed ID: 10686040
[TBL] [Abstract][Full Text] [Related]
13. A 4-week comparison of salmeterol and terbutaline in adult asthma.
Hermansson BA; Jenkins RJ
Allergy; 1995 Jul; 50(7):551-8. PubMed ID: 8588686
[TBL] [Abstract][Full Text] [Related]
14. Comparison of inhaled salmeterol and oral zafirlukast in asthmatic patients using concomitant inhaled corticosteroids.
Nelson HS; Nathan RA; Kalberg C; Yancey SW; Rickard KA
MedGenMed; 2001 Jul; 3(4):3. PubMed ID: 11549982
[TBL] [Abstract][Full Text] [Related]
15. One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients.
Persson G; Baas A; Knight A; Larsen B; Olsson H
Eur Respir J; 1995 Jan; 8(1):34-9. PubMed ID: 7744191
[TBL] [Abstract][Full Text] [Related]
16. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
[TBL] [Abstract][Full Text] [Related]
17. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
[TBL] [Abstract][Full Text] [Related]
18. Inhaled salmeterol and albuterol in asthmatic patients receiving high-dose inhaled corticosteroids.
Lai CK; Chan CH; Ho SS; Hui AC; Lai KN
Chest; 1995 Jul; 108(1):36-40. PubMed ID: 7606988
[TBL] [Abstract][Full Text] [Related]
19. Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
Ullman A; Svedmyr N
Thorax; 1988 Sep; 43(9):674-8. PubMed ID: 2904183
[TBL] [Abstract][Full Text] [Related]
20. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
